Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison

INTRODUCTION: Advances in the treatment of metastatic melanoma have been achieved in recent years: immunotherapies and targeted therapies have demonstrated survival benefits over older agents such as granulocyte-macrophage colony-stimulating factor (GM-CSF), dacarbazine, and glycoprotein peptide vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Casey, Ma, Qiufei, Kudlac, Amber, Palmer, Stephen, Barber, Beth, Zhao, Zhongyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331084/
https://www.ncbi.nlm.nih.gov/pubmed/28000169
http://dx.doi.org/10.1007/s12325-016-0464-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331084/
https://www.ncbi.nlm.nih.gov/pubmed/28000169
http://dx.doi.org/10.1007/s12325-016-0464-9

Ejemplares similares